SOLDANO, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 7.218
AS - Asia 1.166
NA - Nord America 1.043
Continente sconosciuto - Info sul continente non disponibili 251
SA - Sud America 99
AF - Africa 14
OC - Oceania 2
Totale 9.793
Nazione #
IT - Italia 7.031
US - Stati Uniti d'America 984
SG - Singapore 457
CN - Cina 296
VN - Vietnam 189
BD - Bangladesh 86
BR - Brasile 71
FR - Francia 62
HK - Hong Kong 59
CA - Canada 27
IN - India 20
DE - Germania 18
FI - Finlandia 18
PT - Portogallo 17
GB - Regno Unito 16
ID - Indonesia 14
AR - Argentina 13
JP - Giappone 11
ES - Italia 10
JM - Giamaica 9
AT - Austria 7
MX - Messico 7
PH - Filippine 7
EC - Ecuador 6
ZA - Sudafrica 6
IQ - Iraq 5
NL - Olanda 5
PL - Polonia 4
SA - Arabia Saudita 4
SE - Svezia 4
BE - Belgio 3
CR - Costa Rica 3
HN - Honduras 3
IE - Irlanda 3
KR - Corea 3
MY - Malesia 3
PR - Porto Rico 3
PY - Paraguay 3
UA - Ucraina 3
VE - Venezuela 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
GT - Guatemala 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TR - Turchia 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
RE - Reunion 1
RO - Romania 1
RU - Federazione Russa 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 9.542
Città #
Genova 3.660
Genoa 2.354
Vado Ligure 473
Rapallo 453
Singapore 236
San Jose 196
Ashburn 103
Hong Kong 58
Lauterbourg 54
Council Bluffs 51
Ho Chi Minh City 51
Beijing 47
Hanoi 47
New York 47
St Louis 42
Los Angeles 31
Santa Clara 21
Helsinki 14
Boardman 13
Bordighera 12
Milan 12
Frankfurt am Main 11
Haiphong 11
Biên Hòa 10
Porto 10
Chicago 9
Dallas 8
Medford 8
Montreal 8
Da Nang 7
Rome 7
Vienna 7
Atlanta 6
Brooklyn 6
City of London 6
Houston 6
Matosinhos Municipality 6
Phoenix 6
Tokyo 6
Boston 5
Buffalo 5
Gwynn Oak 5
Naples 5
Orem 5
Toronto 5
Washington 5
Dublin 4
Guangzhou 4
Hải Dương 4
Lansdowne 4
Lappeenranta 4
Louisville 4
Newark 4
Ninh Bình 4
Palermo 4
Thái Nguyên 4
Tianjin 4
Waltham 4
Westminster 4
Chennai 3
Dhaka 3
Jakarta 3
Johannesburg 3
Kingston 3
Manchester 3
Mexico City 3
Mumbai 3
Nagīna 3
Nha Trang 3
Nuremberg 3
Orland Park 3
Paris 3
Princeton 3
Queens 3
Quito 3
San Diego 3
San Francisco 3
Spanish Town 3
São Paulo 3
Waunakee 3
Wellington 3
Amsterdam 2
Azusa 2
Baghdad 2
Baltimore 2
Bari 2
Brampton 2
Brasília 2
Campinas 2
Can Tho 2
Catania 2
Charlotte 2
Copenhagen 2
Dayton 2
Denver 2
Des Moines 2
Guatemala City 2
Hangzhou 2
Hemet 2
Hialeah 2
Totale 8.304
Nome #
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 265
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 237
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 235
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 217
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 214
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 202
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 202
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 201
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 198
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 196
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 196
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 195
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 190
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 183
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases 177
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 176
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 171
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 170
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 165
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 162
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. 157
Role of MT1-MMP in the osteogenic differentiation. 156
Circadian rhythms: glucocorticoids and arthritis. 154
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 151
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 148
NF-KB involvement for CTLA4-IG intracellular signaling in human macrophages 148
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 148
Pathophysiology of systemic sclerosis: current understanding and new insights. 148
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 147
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis 145
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis 142
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 137
Estrogen receptors on macrophages in rheumatoid arthritis: target for rheumatic diseases or inflammation-related mechanism? a comparison with peritoneal macrophages from endometriosis 135
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 132
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 131
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 128
The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases 127
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 127
Estrogens modulate the effects of leflunomide on cytokine production by cultures of human monocytic/macrophage cells. 126
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 125
Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis 125
Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. 122
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 119
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 119
Use of glucocorticoids and risk of infections. 119
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 118
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 114
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 113
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 105
Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment. 98
POS0394 AMINAPHTONE SHORT-TERM TREATMENT REDUCES TGF-BETA PLASMA LEVELS IN SYSTEMIC SCLEROSIS PATIENTS WITH SECONDARY RAYNAUD’S PHENOMENON 93
Calcitriol (1,25-Dihydroxy Vitamin D) modulates the aromatase expression and citokina production by cultured human monocytes/macrophages 93
Microvascular damage progression and scoring by capillaroscopy in systemic sclerosis 91
Identification and quantification of selected inflammatory genes modulated by leflunomide and prednisone treatment in early rheumatoid arthritis patients. 86
Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis. 84
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study 84
Fibrosis in sclerodermia: endothelin increases fibronectin production and proliferation of skin Fibroblasts. 83
AB0080 IMBALANCE OF MONOCYTE/MACROPHAGE POLARIZATION IN PERIPHERAL BLOOD AND SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS PATIENTS 83
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY 81
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS 72
AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY 72
Influence of Seasonal Vitamin D Changes on Clinical Manifestations of Rheumatoid Arthritis and Systemic Sclerosis 68
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. 67
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 65
SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES 61
null 58
SAT0293 EXOSOMES DERIVED FROM PLASMA OF SYSTEMIC SCLEROSIS (SSC) PATIENTS AND FROM SSC CULTURED FIBROBLASTS CONTAIN PRO-FIBROTIC MIRNA SIGNATURES AND COULD INDUCE MYOFIBROBLAST DIFFERENTIATION IN VITRO 56
SAT0301 CIRCULATING FIBROCYTES FROM SYSTEMIC SCLEROSIS PATIENTS AS POSSIBLE TARGET OF CTLA4-IG TREATMENT: AN IN VITRO STUDY 55
Endogenous and exogenous environmental hormone D (vitamin D) suppliers in autoimmune rheumatic diseases 50
Understanding the immune-endocrine effects of vitamin D in SARS- CoV-2 infection: a role in protecting against neurodamage? 47
AB0185 Endothelin-1 stimulates the profibrotic alternative activated phenotype in cultured human macrophages isolated from systemic sclerosis patients 46
POS0330 NINTEDANIB (TYROSINE KINASE INHIBITOR) DOWNREGULATES THE TRANSITION OF CULTURED SYSTEMIC SCLEROSIS FIBROCYTES INTO MYOFIBROBLASTS AND THEIR PRO-FIBROTIC ACTIVITY 41
AB0182 In vitro characterization of dermal fibroblasts from systemic sclerosis patients 34
AB0682 CIRCULATING FIBROCYTES IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS PATIENTS: CORRELATION WITH DERMAL THICKNESS 28
AB0183 Isolation and characterization of circulating fibrocytes from systemic sclerosis patients: an vitro investigation 24
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study 24
AB0185 Altered expression of relaxin receptor rxfp1/lgr7 in dermal fibroblasts contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis 21
FRI0423 Effects of selexipag in cultured scleroderma skin fibroblasts 20
FRI0417 Cd86 expression on cultured skin fibroblasts from systemic sclerosis patients: in vitro effects of ctla4-ig 19
FRI0418 In vitro effects of ctla4-ig treatment on cultured fibrocytes from systemic sclerosis patients 19
THU0327 ANTIBODIES AGAINST EXTRACTABLE NUCLEAR ANTIGENS (ENA) IN SCLERODERMA ARE NOT ONLY DIAGNOSTIC AND PROGNOSTIC TOOLS, BUT PATHOGENETIC REGULATORS INDUCING A PROFIBROTIC PHENOTYPE IN CULTURED SKIN FIBROBLASTS 18
SAT0252 AN EVALUATION OF THREE DIFFERENT METHODS TO EVALUATE SKIN IMPAIRMENT IN SYSTEMIC SCLEROSIS PATIENTS 12
OP0212 Endothelin-1 induces a profibrotic phenotype in cultured human microvascular endothelial and circulating monocyte/macrophage cells 10
THU0053 APREMILAST INHIBITS THE TGFî'1 MEDIATED TRANSITION OF CULTURED HUMAN SKIN FIBROBLASTS INTO PROFIBROTIC MYOFIBROBLASTS: IN VITRO STUDY 10
FRI0033 TNFalpha Production In Cultured Human Macrophages after CTLA4-IG (abatacept) In Vitro Treatment 10
THU0116 European multicentre pilot survey to assess vitamin d and clinical status in rheumatoid arthritis patients 9
OP0082 Fibrosis and microangiopathy are the main histopathological hallmarks of scleroderma-related myopathy 8
THU0348 IDENTIFICATION OF CIRCULATING CELLS WITH AN HYBRID M1/M2 MACROPHAGE PHENOTYPE IN SYSTEMIC SCLEROSIS PATIENTS AND CORRELATIONS WITH SELECTED CLINICAL ASPECTS 8
AB0212 Endothelin-1 and Serum from Systemic Sclerosis Patients Promote the Induction of Macrophage M2 Phenotype in Vitro 7
AB0211 CD206+Cell Subset in Systemic Sclerosis Patients: Increased Presence in Peripheral Blood and Skin 7
OP0296 Comparison of Bosentan and Macitentan Effects on Endothelial-To-Mesenchymal Transition Process Induced by ET-1 in Cultured Human Microvascular Endothelial Cells 7
FRI0404 Characterisation of a monocytes/macrophages cell subset co-expressing both m1 and m2 phenotype markers in systemic sclerosis patients 7
THU0525 Counting Synovial Fluid Monosodium Urate Crystals May Be Useful in The Management of Patients with Gout 6
A3.11 Endothelin-1 directly induces a profibrotic phenotype both in human dermal microvascular endothelial cells and skin fibroblasts 6
THU0347 TESTING THE IN VITRO EFFECTS OF NINTEDANIB ON CIRCULATING FIBROCYTES AND RESIDENT SKIN FIBROBLASTS FROM THE SAME SYSTEMIC SCLEROSIS PATIENTS: PRELIMINARY RESULTS 6
SAT0323 The endothelial-to-mesenchymal transition (ENDOMT) in scleroderma can be prevented by the use of dual endothelin receptor antagonists bosentan and macitentan 6
A8.21 Rapid downregulation of inflammatory cytokine production in cultured human macrophages after CTLA4-Ig, dexamethasone, and methotrexate combined treatments 5
A1.13 Increased presence of CD206+ macrophage subset in peripheral blood of systemic sclerosis patients 5
THU0451 A method for counting calcium pyrophosphate crystals in the synovial fluid 5
Totale 9.793
Categoria #
all - tutte 30.104
article - articoli 29.119
book - libri 0
conference - conferenze 640
curatela - curatele 0
other - altro 345
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022678 35 41 59 59 19 35 67 154 40 59 34 76
2022/2023548 49 39 13 38 83 78 7 39 87 10 94 11
2023/2024434 12 42 4 50 25 82 32 45 13 11 39 79
2024/20251.332 58 81 48 79 143 139 121 236 46 127 133 121
2025/20263.359 324 202 235 443 356 242 408 148 292 319 169 221
2026/2027309 309 0 0 0 0 0 0 0 0 0 0 0
Totale 9.793